Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

NCT05722912 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Graft-versus-host Disease (GVHD)

Interventions

DRUG: Ruxolitinib

Sponsor

Incyte Corporation